DC

David R. Clemmons

UH University Of North Carolina At Chapel Hill: 10 patents #48 of 1,688Top 3%
AM Amgen: 1 patents #1,847 of 2,867Top 65%
MC Maine Medical Center: 1 patents #12 of 29Top 45%
UC University Of North Carolina: 1 patents #81 of 213Top 40%
📍 Chapel Hill, NC: #262 of 1,999 inventorsTop 15%
🗺 North Carolina: #3,858 of 45,564 inventorsTop 9%
Overall (All Time): #376,121 of 4,157,543Top 10%
13
Patents All Time

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDate
11192932 Heparin-binding domain of IGFBP-2 in the treatment of metabolic disorders Thomas Delale, Stephane Milano, Thierry Abribat 2021-12-07
10947285 Compounds, compositions and uses thereof for improvement of bone disorders Gang Xi, Thomas Delale, Michel Julien, Thierry Abribat 2021-03-16
9868787 Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-I Laura A. Maile 2018-01-16
9587024 Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1) Laura A. Maile, Michael Naso, Francis Joseph Carr, Timothy David Jones, Simon Keen 2017-03-07
9475882 Antagonists of IAP-SHPS1 interaction Laura A. Maile 2016-10-25
9220746 Compounds and methods for treating bone disorders and controlling weight Clifford Rosen 2015-12-29
9073996 Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1) Laura A. Maile, Michael Naso, Francis Joseph Carr, Timothy David Jones, Simon Keen 2015-07-07
9068000 Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-I Laura A. Maile 2015-06-30
8613922 Methods for inhibiting diabetic retinopathy with an antibody against integrin associated protein (IAP) Laura A. Maile 2013-12-24
8206706 Method for enhancing or inhibiting insulin-like growth factor-I Laura A. Maile 2012-06-26
8187595 Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-I Laura A. Maile 2012-05-29
7723483 Method for enhancing or inhibiting insulin-like growth factor-I Laura A. Maile 2010-05-25
5973115 Method for potentiating and inhibiting insulin-like growth factor activity Walker H. Busby, Jr., Michael T. Brewer, Stephen P. Eisenberg, Robert C. Thompson 1999-10-26